Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness [Phase 1, Phase 2]

View source ↗

Summary

ViaCyte's VC-02 combination product for type 1 diabetes mellitus with hypoglycemia unawareness has completed its Phase 1/2 safety, tolerability, and efficacy st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia Unawareness
• Type 1 Diabetes Mellitus

Drugs mentioned

• VC-02

Snippet

Sponsor: ViaCyte | Conditions: Type 1 Diabetes Mellitus With Hypoglycemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-12-03